At a glance

ClinicalIndex Comparison Record

N/ACompleted· 80 enrolled

Drug / intervention

Electronic drug monitoring feedback databehavioral

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00661258

NCT00661258N/ACompleted

Compare CT.gov

Antiretroviral Treatment Adherence for Life Pilot Study: Phases II and III

Boston University·interventional·Posted Apr 18, 2008·Updated May 15, 2017

In Brief

A clinical study evaluating Electronic drug monitoring feedback data for HIV Infections. Completed, enrolled 80 participants across 1 site.

Detailed Summary

This study focuses on collecting and analyzing quantitative data related to adherence to antiretroviral treatment from patients in Dali, China, over a one-year time-frame and generating preliminary data on an intervention designed to improve adherence to antiretroviral treatment among the study population.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHIV Infections

CountriesChina

CollaboratorsBeijing Ditan Hospital, Second People's Hospital, Dali

Timeline

N/ACompletedFinished

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 2006

Primary CompletionNov 2007

First PostedApr 2008

TodayJul 2026

First PostedApr 18, 2008

Enrollment StartJun 1, 2006

Primary CompletionNov 1, 2007

TodayJul 2, 2026

Enrollment to primary: 1.4 yearsPosted 18.2 years ago

Interventions

Electronic drug monitoring feedback databehavioral

All patients were given electronic drug monitors that can monitor pill-taking behavior. In the intervention arm, patients and their attending doctors were given the electronic drug monitoring data on pill bottle openings at each monthly visit for use in adherence counseling sessions. Control arm patients were not given their electronic drug monitoring feedback data and their counseling sessions were based on self-reported adherence, as per standard of care in Dali.